Inhibition of appetite by nasal leptin administration in rats

International Journal of Obesity

Volumn 29, Issue 7, 2005, Pages 858-863

  Shimizu, H ^a   Oh I, S ^a   Okada, S ^a   Mori, M ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebrospinal fluid; Food intake; Leptin; Nasal drug delivery; Signal transducer and activator of transcription (STAT) 3

Indexed keywords

LEPTIN; LYSOPHOSPHATIDYLCHOLINE; RECOMBINANT LEPTIN; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; APPETITE; ARCUATE NUCLEUS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FOOD INTAKE; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; WEIGHT REDUCTION;

ADMINISTRATION, INHALATION; ANIMALS; APPETITE REGULATION; ARCUATE NUCLEUS; DEPRESSION, CHEMICAL; DNA-BINDING PROTEINS; LEPTIN; LYSOPHOSPHATIDYLCHOLINES; MALE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 21244461519     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802951     Document Type: Article

References (32)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
3. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
4. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in human. Nature 1997; 387: 903-908.
5. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401.
6. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte Jr D. Cerebrospinal fluid leptin levels: relationship to plasma levels and adiposity in humans. Nat Med 1996; 2: 589-593.
7. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17: 305-311.
8. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 140-141.
9. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M. Recombinant leptin for weight loss in obese and lean adults. JAMA 1999; 282: 1568-1575.
10. Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 2000; 11: 1-18.
11. Lawrence D. Intranasal delivery could be used to administer drugs directly to the brain. Lancet 2002; 359: 1674.
12. Hussain A, Foster T, Hirai S, Kashihara T, Batenhorst R, Jones M. Nasal absorption of propranolol in humans. J Pharm Sci 1980; 69: 1240-1242.
13. Gizurarson S, Thorvaldsson T, Sigurdsson P, Gunnarsson E. Selective delivery of insulin into the brain: intraolfactory absorption. Int J Pharm 1996; 140: 77-83.
14. Yaksh TL, Scott B, LeBel CL. Effect of continuous lumbar intrathecal infusion of leptin in rats on weight regulation. Neuroscience 2002; 110: 703-710.
15. O'Hagan DT, Critchley H, Farraj NF, Fisher AN, Johansen BR, Davis SS, Illum L. Nasal absorption enhancers for biosynthetic human growth hormone in rats. Pharm Res 1990; 7: 772-776.
16. Behl CR, Pimplaskar HK, Sileno AP, Xia WJ, Gries WJ, deMeireles JC, Romeo VD. Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv Drug Deliv Rev 1998; 29: 117-133.
17. Seki T, Sato N, Hasegawa T, Kawaguchi T, Juni K. Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats. Biol Pharm Bull 1994; 17: 1135-1137.
18. Chen XQ, Fawcett JR, Rahman YE, Ala TA, Frey WH. Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimer's Dis 1998; 1: 35-44.
19. Hosoi T, Kawaguchi T, Okuma Y, Tanaka J, Nomura Y. Brain stem is a direct target for leptin's action in the central nervous system. Endocrinology 2002; 143: 3498-3504.
20. Hubschule T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W. Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci 2001; 21: 2413-2424.
21. McCowen KC, Chow JC, Smith RJ. Leptin signaling in the hypothalamus of normal rats in vivo. Endocrinology 1998; 139: 4442-4447.
22. Vaisse C, Halaas JL, Horvath CM, Darnell Jr JE, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14: 95-97.
23. Thorne RG, Emory CR, Ala TA, Frey WH. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res 1995; 692: 278-283.
24. Kastin AJ, Pan W, Maness LM, Koletsky RJ, Ernberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 1999; 20: 1449-1453.
25. Peiser C, McGregor GP, Lang RE. Binding and internalization of leptin by porcine choroids plexus cells in culture. Neurosci Lett 2000; 14: 209-212.
26. Fujioka K, Patane J, Lubina J, Lau D. CSF leptin levels after exogenous administration of recombinant methionyl human leptin. JAMA 1999; 282: 1517-1518.
27. Seufert J, Kieffer TJ, Leech CA, Holz GG, Moritz W, Ricordi C, Habener JF. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 670-676.
28. Bordary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002; 287: 1706-1709.
29. Artwohl M, Roden M, Holzenbein T, Freudenthaler A, Waldhaus W, Baumgartner-Parzer SM. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 2002; 26: 577-580.
30. Shibuya I, Utsunomiya K, Toyohira Y, Ueno S, Tsutsui M, Cheah TB, Ueta Y, Izumi F, Yanagihara N. Regulation of catecholamine synthesis by leptin. Ann NY Acad Sci 2002; 971: 522-527.
31. Tsuchiya T, Shimizu H, Horie T, Mori M. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 1999; 22: 273-279.
32. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 2002; 39: 1-11.